Telangana gears up to vaccinate 80 lakh people in first phase
Telangana is in the process of creating the required infrastructure for administering Covid-19 vaccine doses to about 80 lakh people in the first phase, once the preventive medicine is available for the state, PTI quoted government sources as saying.
“Even if one vaccinator administers 100 people a day, on an average 10,000 vaccinators can vaccinate 80 lakh people in eight or ten days,” a Health department official told PTI.
Vaccination will be done at all government health facilities such as primary health centers, district hospitals and teaching facilities, the official said.
Bharat Biotech’s Covid vaccine produces robust immune response
Cipla launches Covid-19 rapid antigen test kits in India
FILE PHOTO: Employees and security staff work at the reception area of Cipla at its headquarters in Mumbai.
(REUTERS)Premium
Share Via
Read Full Story
Pharma major Cipla on Wednesday announced its partnership with the Premier Medical Corporation Pvt Ltd for commercialisation of the rapid antigen test kits for COVID-19 in India. In this collaboration, Cipla will be responsible for the marketing and distribution of the Rapid Antigen Detection Test for the qualitative detection of SARS-CoV-2 antigen that will be manufactured by Premier Medical Corporation Pvt Ltd, Cipla said in a regulatory filing.
PTI
New Delhi |
Updated on
December 16, 2020
×
Company to commence supply from this week; test to be marketed under the brand name ‘CIPtest’ Drug major Cipla on Wednesday announced its partnership with the Premier Medical Corporation Pvt Ltd for commercialisation of the rapid antigen test kits for Covid-19 in India. “In this collaboration, Cipla will be responsible for the marketing and distribution of the Rapid Antigen Detection Test for the qualitative detection of SARS-CoV-2 antigen that will be manufactured by Premier Medical Corporation Pvt Ltd,” Cipla said in a regulatory filing. The company said it will commence supply of rapid point-of-care nasopharyngeal swab tests from this week.
COVID-19 | Cipla partners with Premier Medical Corporation to launch rapid antigen test kits in India thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
Coronavirus | Cipla partners with Premier Medical Corporation to launch rapid antigen test kits in India
Updated:
Updated:
December 16, 2020 23:09 IST
The company said it will commence supply of rapid point-of-care nasopharyngeal swab tests from this week.
Share Article
The company said it will commence supply of rapid point-of-care nasopharyngeal swab tests from this week. Drug major Cipla on Wednesday announced its partnership with the Premier Medical Corporation Private Limited for commercialisation of the rapid antigen test kits for coronavirus (COVID-19) in India. “In this collaboration, Cipla will be responsible for the marketing and distribution of the Rapid Antigen Detection Test for the qualitative detection of SARS-CoV-2 antigen that will be manufactured by Premier Medical Corporation Private Limited,” Cipla said in a regulatory filing.